drugset / Trial / NCT00234897

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

NCT00234897

Phase 4 Completed 1938 enrolled Abbott
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

Timeline

Start
2004-08
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adalimumab Monoclonal antibody

Indications